🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of BEVAMAINT is to improve benefic effect of maintenance therapy af...
Status
Active Not Recruiting
Location
Chu Dijon Bourgogne
Start Date
2020-01-27
Trial ID
NCT04188145
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as leucovorin, fluorouracil, an...
Status
Completed
Location
Hopital Saint Andre
Start Date
2006-10
Trial ID
NCT00544349
Treatments Being Tested
Investigating the efficacy of Cetuximab Monotherapy versus Continuation aft...
Status
Unknown
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02978313
The pancreas cancer is the 4th cause of death. All stage confused, the surv...
Status
Completed
Location
CHU - Hôtel Dieu
Start Date
2015-01-12
Trial ID
NCT02352337
Treatments Being Tested
The main objective of this randomized trial is to compare 5FU/LV (Mayo-Clin...
Status
Unknown
Location
AERO
Start Date
TBD
Trial ID
NCT00189657
Treatments Being Tested
Oxaliplatin ± nivolumab in combination with trifluridine/tipiracil or 5-flu...
Status
Active Not Recruiting
Location
Clinique de l'Europe
Start Date
2023-06-23
Trial ID
NCT05476796
Treatments Being Tested
Cytotoxic chemotherapy is usually scaled to the body surface area (BSA), an...
Status
Active Not Recruiting
Location
Hôpital Européen
Start Date
2017-11-01
Trial ID
NCT03255434
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as leucovorin calcium, fluorour...
Status
Completed
Location
Hôpital Avicenne
Start Date
2011-07
Trial ID
NCT01417494
Colorectal cancer is the 3rd most common cancer in France and the 2nd cause...
Status
Recruiting
Location
Hôpital Erasme
Start Date
2016-12
Trial ID
NCT02885753
5-fluorouracil (5-FU) is a standard of care in frail/elderly patients with ...
Status
Not Yet Recruiting
Location
ICO site Paul Papin
Start Date
2025-08-31
Trial ID
NCT07124884
Treatments Being Tested